bioAffinity Technologies, Inc. Amortization of Intangible Assets
bioAffinity Technologies, Inc. (BIAF) reported Amortization of Intangible Assets of $29.17 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-07
- bioAffinity Technologies, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $14.58K, a 0.01% increase year-over-year.
- bioAffinity Technologies, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $14.58K, a 0.00% change year-over-year.
- bioAffinity Technologies, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $14.58K, a 0.00% change year-over-year.
- bioAffinity Technologies, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $14.58K, a 0.00% change year-over-year.
- bioAffinity Technologies, Inc. amortization of intangible assets for fiscal 2025 was $58.33K, a 0.00% change from fiscal 2024.
- bioAffinity Technologies, Inc. amortization of intangible assets for fiscal 2024 was $58.33K, a 252.94% increase from fiscal 2023.
- bioAffinity Technologies, Inc. amortization of intangible assets for fiscal 2023 was $16.53K.
- bioAffinity Technologies, Inc. amortization of intangible assets for fiscal 2022 was $0.00.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $29.17K 10-Q · filed 2026-08-07 | $43.75K derived: sum of 3 quarters · filed 2026-08-07 | $58.33K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $14.58K 10-Q · filed 2026-05-11 | $29.17K derived: sum of 2 quarters · filed 2026-05-11 | $43.75K derived: sum of 3 quarters · filed 2026-05-11 | $58.33K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2025-12-31 | $14.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $29.17K derived: sum of 2 quarters · filed 2026-03-16 | $43.75K derived: sum of 3 quarters · filed 2026-03-16 | $58.33K 10-K · filed 2026-03-16 | |||
| 2025-09-30 | $14.58K 10-Q · filed 2025-11-14 | $29.17K derived: sum of 2 quarters · filed 2025-11-14 | $43.75K 10-Q · filed 2025-11-14 | $58.33K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2025-06-30 | $14.58K 10-Q · filed 2025-08-14 | $14.58K 10-Q · filed 2026-08-07 | $29.17K 10-Q · filed 2025-08-14 | $43.75K derived: sum of 3 quarters · filed 2026-05-11 | $58.33K derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2025-03-31 | $14.58K 10-Q · filed 2026-05-11 | $29.17K derived: sum of 2 quarters · filed 2026-05-11 | $43.75K derived: sum of 3 quarters · filed 2026-05-11 | $58.33K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $14.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $29.17K derived: sum of 2 quarters · filed 2026-03-16 | $43.75K derived: sum of 3 quarters · filed 2026-03-16 | $58.33K 10-K · filed 2026-03-16 | $58.33K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $14.58K 10-Q · filed 2025-11-14 | $29.17K derived: sum of 2 quarters · filed 2025-11-14 | $43.75K 10-Q · filed 2025-11-14 | $58.33K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $14.58K 10-Q · filed 2025-08-14 | $14.54K 10-Q · filed 2024-08-14 | $29.17K 10-Q · filed 2025-08-14 | $43.75K derived: sum of 3 quarters · filed 2025-08-14 | $45.69K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $14.58K 10-Q · filed 2025-05-15 | $29.17K derived: sum of 2 quarters · filed 2025-05-15 | $31.11K derived: sum of 3 quarters · filed 2025-05-15 | $31.11K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $14.59K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $16.53K derived: sum of 2 quarters · filed 2025-03-31 | $16.53K derived: sum of 3 quarters · filed 2025-03-31 | $16.53K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $1.94K 10-Q · filed 2024-11-14 | $1.94K derived: sum of 2 quarters · filed 2024-11-14 | $1.94K 10-Q · filed 2024-11-14 | $1.94K derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | $0.00 derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 derived: sum of 3 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |